Barclays PLC Karuna Therapeutics, Inc. Transaction History

Barclays PLC

  • $377 Billion
  • Q3 2024

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 15, 2024
BUY
$161.01 - $317.85 $1.31 Million - $2.59 Million
8,152 Added 11.03%
82,074 $26 Million
Q3 2023

Nov 07, 2023
SELL
$164.66 - $218.08 $1.71 Million - $2.27 Million
-10,394 Reduced 12.33%
73,922 $12.5 Million
Q2 2023

Aug 03, 2023
BUY
$176.32 - $240.22 $9.82 Million - $13.4 Million
55,707 Added 194.72%
84,316 $18.3 Million
Q1 2023

May 04, 2023
SELL
$161.33 - $204.36 $134,871 - $170,844
-836 Reduced 2.84%
28,609 $5.2 Million
Q4 2022

Feb 13, 2023
SELL
$191.53 - $236.82 $316,599 - $391,463
-1,653 Reduced 5.32%
29,445 $5.79 Million
Q3 2022

Nov 03, 2022
BUY
$123.79 - $277.42 $3.55 Million - $7.96 Million
28,682 Added 1187.17%
31,098 $6.99 Million
Q2 2022

Aug 12, 2022
SELL
$93.97 - $143.33 $704,117 - $1.07 Million
-7,493 Reduced 75.62%
2,416 $306,000
Q1 2022

May 16, 2022
SELL
$98.9 - $132.37 $3.03 Million - $4.05 Million
-30,619 Reduced 75.55%
9,909 $1.26 Million
Q4 2021

Feb 14, 2022
BUY
$110.64 - $159.4 $2.39 Million - $3.44 Million
21,575 Added 113.83%
40,528 $5.31 Million
Q3 2021

Nov 09, 2021
BUY
$101.2 - $125.87 $159,896 - $198,874
1,580 Added 9.09%
18,953 $2.32 Million
Q2 2021

Aug 13, 2021
SELL
$107.45 - $135.95 $1.39 Million - $1.76 Million
-12,930 Reduced 42.67%
17,373 $1.98 Million
Q1 2021

May 13, 2021
SELL
$95.46 - $133.08 $994,693 - $1.39 Million
-10,420 Reduced 25.59%
30,303 $3.64 Million
Q4 2020

Feb 11, 2021
BUY
$75.23 - $109.23 $2.44 Million - $3.55 Million
32,476 Added 393.79%
40,723 $4.14 Million
Q3 2020

Nov 12, 2020
SELL
$71.31 - $109.74 $74,732 - $115,007
-1,048 Reduced 11.27%
8,247 $637,000
Q2 2020

Aug 12, 2020
BUY
$62.14 - $117.21 $341,521 - $644,186
5,496 Added 144.67%
9,295 $1.04 Million
Q1 2020

May 13, 2020
SELL
$60.41 - $115.92 $80,828 - $155,100
-1,338 Reduced 26.05%
3,799 $274,000
Q4 2019

Feb 10, 2020
BUY
$11.44 - $123.99 $32,935 - $356,967
2,879 Added 127.5%
5,137 $387,000
Q3 2019

Nov 14, 2019
BUY
$16.05 - $27.35 $36,240 - $61,756
2,258 New
2,258 $37,000

Others Institutions Holding KRTX

# of Institutions
10
Shares Held
332K
Call Options Held
0
Put Options Held
0
View Full List

About Karuna Therapeutics, Inc.

KRTX Quotes by TradingView
  • Ticker KRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 33,965,000
  • Description
  • Karuna Therapeutics, Inc., a clinical-stage biopharmaceutical company, creates and delivers transformative medicines for people living with psychiatric and neurological conditions. Its lead product candidate is KarXT, an oral modulator of muscarinic receptors that is in Phase III clinical trial for the treatment of acute psychosis in patients wi...
More about KRTX
Track This Portfolio

Track Barclays PLC Portfolio

Follow Barclays PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email